pathology-congress-2017-keynote

4 / 7

Volume 7, Issue 5 (Suppl) J Clin Exp Pathol
ISSN: 2161-0681 JCEP, an open access journal Pathology Congress 2017
November 13-14, 2017
Page 13
conferenceseries.com
NOVEMBER 13-14, 2017 OSAKA, JAPAN
14th Asia Pacific Pathology Congress
Harnessing the power of molecular diagnostics in pathology practice: Lessons from the world of leukemia
Molecular diagnostics and personalized medicine is revolutionizing the way we approach medicine and treatment of
disease. Hematopathology was one of the first of the pathology subspecialties to welcome molecular classification into its
classification scheme when it introduced the WHO classification in 2001. Since then, the validity and importance of molecular
data has increased million folds and continues to increase every day. As pathologists, we need to harness and embrace the
power of molecular pathology in our daily practice and hematopathology has led the way. This lecture serves as a historical
overview from the discovery of the t(9;22) in CML and the inclusion of the "AMLs with recurrent cytogenetic abnormalities"
and how the classification scheme has evolved from WHO 2001, to 2008 and now to 2016. This lecture serve to update the
audience on the changes in the WHO 2016 update to leukemia diagnosis in the WHO classification, discuss next generation
sequencing and where its utility stands in the diagnosis of leukemia and the future of the field.
Biography
Kamran Muhammad Mirza has completed his MBBS from the Aga Khan University in Karachi, Pakistan and PhD from University of Illinois in Chicago, IL. He
was trained in Combined Anatomic and Clinical Pathology with Fellowships in Hematopathology, Thoracic Pathology and Medical Education at the University
of Chicago. He is an Assistant Professor of Pathology and Medical Director of Molecular Pathology at Loyola University Chicago Stritch School of Medicine in
Maywood, IL. He is the recipient of numerous pathologist-in-training awards, teacher-of-the year awards and honors such as induction into the Alpha Omega Alpha
honor society and selection into American Society for Clinical Pathology's 40 Under Forty 2017.
Kamran Muhammad Mirza
Loyola University Chicago Stritch School of Medicine, USA
Kamran Muhammad Mirza, J Clin Exp Pathol 2017, 7:5 (Suppl)
DOI: 10.4172/2161-0681-C1-039